Arbutus Biopharma Corp Comprehensive Income
Arbutus Biopharma Corp (ABUS) reported Comprehensive Income of -$5.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-12
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$5.19M, a 307.51% decline year-over-year.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $169.60M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$3.73M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.68M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$33.46M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$69.63M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$70.78M.
- Arbutus Biopharma Corp comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$71.61M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$5.19M 10-Q · filed 2026-08-12 | $164.41M 10-Q · filed 2026-08-12 | $160.68M derived: sum of 3 quarters · filed 2026-08-12 | $153.00M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $169.60M 10-Q · filed 2026-05-13 | $165.87M derived: sum of 2 quarters · filed 2026-05-13 | $158.19M derived: sum of 3 quarters · filed 2026-05-13 | $160.69M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$11.41M derived: sum of 2 quarters · filed 2026-03-23 | -$8.91M derived: sum of 3 quarters · filed 2026-08-12 | -$33.46M 10-K · filed 2026-03-23 | |
| 2025-09-30 | -$7.68M 10-Q · filed 2025-11-13 | -$5.18M derived: sum of 2 quarters · filed 2026-08-12 | -$29.74M 10-Q · filed 2025-11-13 | -$42.32M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $2.50M 10-Q · filed 2026-08-12 | -$22.05M 10-Q · filed 2026-08-12 | -$34.63M derived: sum of 3 quarters · filed 2026-08-12 | -$54.13M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$24.56M 10-Q · filed 2026-05-13 | -$37.13M derived: sum of 2 quarters · filed 2026-05-13 | -$56.63M derived: sum of 3 quarters · filed 2026-05-13 | -$76.37M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$32.08M derived: sum of 2 quarters · filed 2026-03-23 | -$51.81M derived: sum of 3 quarters · filed 2026-03-23 | -$69.63M 10-K · filed 2026-03-23 | |
| 2024-09-30 | -$19.50M 10-Q · filed 2025-11-13 | -$39.23M derived: sum of 2 quarters · filed 2025-11-13 | -$57.06M 10-Q · filed 2025-11-13 | -$75.91M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$19.73M 10-Q · filed 2025-08-06 | -$37.56M 10-Q · filed 2025-08-06 | -$56.41M derived: sum of 3 quarters · filed 2025-08-06 | -$75.93M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | -$17.82M 10-Q · filed 2025-05-14 | -$36.67M derived: sum of 2 quarters · filed 2025-05-14 | -$56.19M derived: sum of 3 quarters · filed 2025-05-14 | -$73.12M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$18.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$38.37M derived: sum of 2 quarters · filed 2025-03-27 | -$55.30M derived: sum of 3 quarters · filed 2025-03-27 | -$70.78M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$19.52M 10-Q · filed 2024-11-06 | -$36.45M derived: sum of 2 quarters · filed 2024-11-06 | -$51.93M 10-Q · filed 2024-11-06 | -$73.35M derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | -$16.93M 10-Q · filed 2024-08-08 | -$32.41M 10-Q · filed 2024-08-08 | -$53.83M derived: sum of 3 quarters · filed 2024-08-08 | -$72.30M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$15.48M 10-Q · filed 2024-05-02 | -$36.90M derived: sum of 2 quarters · filed 2024-05-02 | -$55.38M derived: sum of 3 quarters · filed 2024-05-02 | -$70.26M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | -$21.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$39.89M derived: sum of 2 quarters · filed 2024-03-05 | -$54.77M derived: sum of 3 quarters · filed 2024-03-05 | -$71.61M 10-K · filed 2024-03-05 | |
| 2022-09-30 | -$18.47M 10-Q · filed 2023-11-07 | -$33.36M derived: sum of 2 quarters · filed 2023-11-07 | -$50.19M 10-Q · filed 2023-11-07 | -$71.66M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$14.88M 10-Q · filed 2023-08-03 | -$31.72M 10-Q · filed 2023-08-03 | -$53.19M derived: sum of 3 quarters · filed 2023-08-03 | -$72.38M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$16.84M 10-Q · filed 2023-05-04 | -$38.30M derived: sum of 2 quarters · filed 2023-05-04 | -$57.49M derived: sum of 3 quarters · filed 2023-05-04 | -$76.91M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$21.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$40.66M derived: sum of 2 quarters · filed 2023-03-02 | -$60.08M derived: sum of 3 quarters · filed 2023-03-02 | -$76.41M 10-K · filed 2023-03-02 | |
| 2021-09-30 | -$19.19M 10-Q · filed 2022-11-09 | -$38.61M derived: sum of 2 quarters · filed 2022-11-09 | -$54.94M 10-Q · filed 2022-11-09 | -$72.07M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$19.42M 10-Q · filed 2022-08-04 | -$35.80M 10-Q · filed 2022-08-04 | -$52.88M derived: sum of 3 quarters · filed 2022-08-04 | -$71.67M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | -$16.38M 10-Q · filed 2022-05-05 | -$33.46M derived: sum of 2 quarters · filed 2022-05-05 | -$52.25M derived: sum of 3 quarters · filed 2022-05-05 | -$66.21M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$17.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$35.87M derived: sum of 2 quarters · filed 2022-03-03 | -$49.83M derived: sum of 3 quarters · filed 2022-03-03 | -$63.69M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$18.78M 10-Q · filed 2021-11-04 | -$32.75M derived: sum of 2 quarters · filed 2021-11-04 | -$46.60M 10-Q · filed 2021-11-04 | -$71.02M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$13.96M 10-Q · filed 2021-08-05 | -$27.82M 10-Q · filed 2021-08-05 | -$52.24M derived: sum of 3 quarters · filed 2021-08-05 | -$134.72M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | -$13.61M 10-Q · filed 2021-05-05 | -$38.28M derived: sum of 2 quarters · filed 2021-05-05 | -$120.75M derived: sum of 3 quarters · filed 2021-05-05 | -$144.12M derived: sum of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | -$24.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$107.14M derived: sum of 2 quarters · filed 2021-03-04 | -$130.51M derived: sum of 3 quarters · filed 2021-03-04 | -$153.78M 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$82.48M 10-Q · filed 2020-11-05 | -$105.84M derived: sum of 2 quarters · filed 2020-11-05 | -$129.12M 10-Q · filed 2020-11-05 | -$147.34M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | -$23.37M 10-Q · filed 2020-08-07 | -$46.64M 10-Q · filed 2020-08-07 | -$64.86M derived: sum of 3 quarters · filed 2020-08-07 | -$89.35M derived: sum of 4 quarters · filed 2020-08-07 | |
| 2019-03-31 | -$23.27M 10-Q · filed 2020-05-11 | -$41.49M derived: sum of 2 quarters · filed 2020-05-11 | -$65.98M derived: sum of 3 quarters · filed 2020-05-11 | -$62.89M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$18.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$42.71M derived: sum of 2 quarters · filed 2020-03-05 | -$39.62M derived: sum of 3 quarters · filed 2020-03-05 | -$57.05M 10-K · filed 2020-03-05 | |
| 2018-09-30 | -$24.48M 10-Q · filed 2019-11-06 | -$21.39M derived: sum of 2 quarters · filed 2019-11-06 | -$38.82M 10-Q · filed 2019-11-06 | -$74.75M derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | $3.09M 10-Q · filed 2019-08-05 | -$14.34M 10-Q · filed 2019-08-05 | -$50.27M derived: sum of 3 quarters · filed 2019-08-05 | -$61.87M derived: sum of 4 quarters · filed 2019-08-05 | |
| 2018-03-31 | -$17.43M 10-Q · filed 2019-05-06 | -$53.36M derived: sum of 2 quarters · filed 2019-05-06 | -$64.96M derived: sum of 3 quarters · filed 2019-05-06 | ||
| 2017-12-31 | -$35.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$47.53M derived: sum of 2 quarters · filed 2019-03-07 | -$84.41M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | -$11.60M 10-Q · filed 2018-11-07 | -$48.48M 10-Q · filed 2018-11-07 | |||
| 2016-12-31 | -$218.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$238.29M derived: sum of 2 quarters · filed 2018-03-16 | -$368.29M derived: sum of 3 quarters · filed 2018-03-16 | -$384.16M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$19.59M 10-Q · filed 2016-11-03 | -$149.59M derived: sum of 2 quarters · filed 2016-11-03 | -$165.47M 10-Q · filed 2016-11-03 | -$178.93M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-06-30 | -$130.00M 10-Q · filed 2016-08-04 | -$145.87M 10-Q · filed 2016-08-04 | -$159.33M derived: sum of 3 quarters · filed 2018-03-16 | -$198.41M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2016-03-31 | -$15.87M 10-Q · filed 2016-05-04 | -$29.33M derived: sum of 2 quarters · filed 2018-03-16 | -$68.42M derived: sum of 3 quarters · filed 2018-03-16 | -$80.08M derived: sum of 4 quarters · filed 2018-03-16 | |
| 2015-12-31 | -$13.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$52.54M derived: sum of 2 quarters · filed 2018-03-16 | -$64.20M derived: sum of 3 quarters · filed 2018-03-16 | -$88.59M 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$39.08M 10-Q · filed 2016-11-03 | -$50.75M derived: sum of 2 quarters · filed 2016-11-03 | -$75.13M 10-Q · filed 2016-11-03 | -$81.36M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-06-30 | -$11.66M 10-Q · filed 2016-08-04 | -$32.83M 10-Q · filed 2016-08-04 | -$42.27M derived: sum of 3 quarters · filed 2017-03-22 | -$55.70M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-03-31 | -$21.16M 10-Q · filed 2016-05-04 | -$30.61M derived: sum of 2 quarters · filed 2017-03-22 | -$44.04M derived: sum of 3 quarters · filed 2017-03-22 | -$46.35M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2014-12-31 | -$9.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$22.88M derived: sum of 2 quarters · filed 2017-03-22 | -$25.18M derived: sum of 3 quarters · filed 2017-03-22 | -$45.33M 10-K · filed 2017-03-22 | |
| 2014-09-30 | -$13.43M 10-Q · filed 2015-11-05 | -$15.74M derived: sum of 2 quarters · filed 2015-11-05 | -$35.88M 10-Q · filed 2015-11-05 | -$40.21M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-06-30 | -$2.31M 10-Q · filed 2015-08-07 | -$22.45M 10-Q · filed 2015-08-07 | -$26.78M derived: sum of 3 quarters · filed 2016-03-09 | -$31.98M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-03-31 | -$20.14M 10-Q · filed 2015-05-06 | -$24.48M derived: sum of 2 quarters · filed 2016-03-09 | -$29.67M derived: sum of 3 quarters · filed 2016-03-09 | -$33.92M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2013-12-31 | -$4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$9.53M derived: sum of 2 quarters · filed 2016-03-09 | -$13.78M derived: sum of 3 quarters · filed 2016-03-09 | -$17.20M 10-K · filed 2016-03-09 | -$17.20M 6-K · filed 2014-03-06 |
| 2013-09-30 | -$5.20M 10-Q · filed 2014-11-07 | -$9.45M derived: sum of 2 quarters · filed 2014-11-07 | -$12.87M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$4.25M 10-Q · filed 2014-08-14 | -$7.67M 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | -$3.42M 10-Q · filed 2014-05-14 | ||||
| 2012-12-31 | $30.09M 10-K · filed 2015-03-13 | $30.09M 6-K · filed 2014-03-06 | |||
| 2011-12-31 | -$10.14M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |